Carlsmed, Inc. (CARL) Fair Value 2026

CARL · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.3 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (20/100)

Quick Summary — As of 2026-08-28, Carlsmed, Inc. (CARL) trades at $16.88. QOC: 6.3/10. Value Trap Risk: 20/100 (SAFE). 0/13 models active.

Key Facts

Ticker
CARL
Price
$16.88
Quality Score
6.3/10
Value Trap Risk
20/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give CARL?

0 Intrinsic Value Models vs. Current Price ($16.88)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Carlsmed, Inc. (CARL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Carlsmed, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About CARL?

0 of 13 models are currently active for CARL. See which stocks rank higher →

How Does CARL Rank in Health Information Services?

Among 55 Health Information Services stocks, CARL ranks #29 by Quality of Company score. CirclFi's QOC score of 6.3/10 evaluates 32 fundamental signals. A score of 6.3 indicates above-average quality.

See all Most Undervalued Health Information Services Stocks →

Carlsmed, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is CARL a Value Trap?

CirclFi's Value Trap algorithm assigns CARL a score of 20/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Carlsmed, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Carlsmed, Inc. earns a quality score of 6.3/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CARL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Carlsmed, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

10 related Health Information Services stocks with 13-model coverage

HCATHealth Catalyst, Inc.QOC 6.3BFRGBullfrog AI Holdings, Inc.QOC 6.2HNGEHinge Health, Inc.QOC 6.4CRVWCareView Communications, Inc.QOC 6.2TEMTempus AI, Inc.QOC 6.4HTFLHeartflow, Inc.QOC 6.1LGMKLogicMark, Inc.QOC 4.9DOCSDoximity, Inc.QOC 9.6LFMDLifeMD, Inc.QOC 7.5HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: HCAT · BFRG · HNGE · CRVW · TEM · HTFL · LGMK · DOCS · LFMD · HQY

Which Other Stocks Have a Similar Quality Score to CARL?

7 companies across all industries closest to CARL’s Quality of Company score of 6.3/10.

CMCMCheetah Mobile Inc.QOC 6.3INDIindie Semiconductor, Inc.QOC 6.3BWMGBrownie's Marine Group, Inc.QOC 6.3PKPark Hotels & Resorts Inc.QOC 6.3ECVTEcovyst Inc.QOC 6.3CVRChicago Rivet & Machine Co.QOC 6.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CMCM · INDI · BWMG · PK · ECVT · CVR · NVDA

Where Does CARL Sit in CirclFi's Health Information Services Rankings?

CARL is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Carlsmed, Inc.’s Valuation?

What is Carlsmed, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Carlsmed, Inc. (CARL). The Quality of Company score is 6.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CARL overvalued or undervalued right now?

At $16.88, 0 of 0 active models suggest CARL may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Carlsmed, Inc.'s business model in Health Information Services.

What does a Quality of Company score of 6.3 mean for CARL?

Carlsmed, Inc.'s QOC of 6.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CARL?

CirclFi analyzes CARL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is CARL a value trap in 2026?

Carlsmed, Inc.'s Value Trap score is 20/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Carlsmed, Inc. (CARL) a Quality of Company score of 6.3/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/CARL/ · Methodology
Primary sources for this CARL valuation
  • Financial statements: Carlsmed, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001794546) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CARL as of ; valuations recomputed .